BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/29/2024 7:55:30 AM | Browse: 64 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 99474
Country China
Category Oncology
Manuscript Type Basic Study
Article Title Effects of invigorating-spleen and anticancer prescription on extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway in colon cancer mice model
Manuscript Source Unsolicited Manuscript
All Author List Wei Wang, Jing Wang, Xiu-Xiu Ren, Hai-Long Yue and Zheng Li
Funding Agency and Grant Number
Funding Agency Grant Number
Liaoning Provincial Science and Technology Department Project 2023JH2/101700149
Open Fund Project of Liaoning University of Traditional Chinese Medicine zyzx2205
Corresponding Author Zheng Li, MD, Chief Physician, Department of Integrated Traditional Chinese and Western Medicine Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning Province, China. fox_dl1984@163.com
Key Words Colon cancer; Invigorating-spleen and anticancer formula; Extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway; Mice model; C-MYC
Core Tip The incidence and mortality of intestinal cancer is increasing year by year. Due to the limited therapeutic means and low survival rate of advanced patients, and the easy development of drug resistance to chemotherapy, targeting and immunotherapy, we have found that spleen-healthy anticancer formula can play an anti-tumor role through the extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling pathway and inhibit the expression of matrix metalloproteinase 2 and c-myc.
Citation Wang W, Wang J, Ren XX, Yue HL, Li Z. Effects of invigorating-spleen and anticancer prescription on extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway in colon cancer mice model. World J Gastrointest Oncol 2024; In press
Received
2024-08-06 08:35
Peer-Review Started
2024-08-06 08:35
To Make the First Decision
Return for Revision
2024-08-26 10:17
Revised
2024-09-06 11:46
Second Decision
2024-09-29 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-09-29 07:55
Articles in Press
2024-09-29 07:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com